Masatoshi Kudo, MD, PhD, Kindai University Faculty of Medicine
Advertisement
Articles by Masatoshi Kudo, MD, PhD, Kindai University Faculty of Medicine
Advertisement
Latest Updated Articles
Frontline I/O: Clinical Trial OverviewsPublished: June 29th 2020 | Updated:
R/R HCC: Second-Line OptionsPublished: June 29th 2020 | Updated:
REACH and REACH2 Trial OverviewPublished: June 29th 2020 | Updated:
I/O Second-Line TreatmentPublished: June 29th 2020 | Updated:
HCC Treatment Algorithm: Asia and EuropePublished: June 29th 2020 | Updated:
Frontline Therapy: Promising I/O CombinationsPublished: June 29th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Single-Center, Retrospective Data Show Low Rate of Lifileucel Infusion Following Referral in Advanced Melanoma
2
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
3
Outcomes With Bridging Therapy Correlate With Cilta-Cel Efficacy, Safety in Multiple Myeloma
4
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
5